Viewing Study NCT01037556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-28 @ 7:47 PM
Study NCT ID: NCT01037556
Status: UNKNOWN
Last Update Posted: 2012-08-31
First Post: 2009-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia
Sponsor: Proacta, Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Acute Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AML View
None Acute Myeloid Leukemia View
None Acute Myelogenous Leukemia View
None Refractory AML View
None Relapsed AML View
None Refractory Acute Myeloid Leukemia View
None Relapsed Acute Myeloid Leukemia View
None Refractory Acute Myelogenous Leukemia View
None Relapsed Acute Myelogenous Leukemia View
None ALL View
None Acute Lymphocytic Leukemia View
None Relapsed Acute Lymphocytic Leukemia View
None Refractory Acute Lymphocytic Leukemia View
None Relapsed ALL View
None Refractory ALL View